News

US FDA centers to deploy AI internally, following experimental run
The U.S. Food and Drug Administration said on Thursday all its centers will deploy artificial intelligence internally ...
Novavax says talks with FDA on COVID vaccine approval ongoing calming investor fears
Novavax on Thursday tried to calm investors spooked by the delay of full approval of its COVID vaccine shot by U.S.
U.S. FDA approves Verastem's cancer therapy
The U.S. Food and Drug Administration has approved Verastem's combination therapy for patients with a type of ovarian cancer ...
US FDA advisers to discuss COVID-19 vaccine recommendations on May 22
The U.S. Food and Drug Administration said on Wednesday it will hold a meeting of experts on May 22 to discuss COVID-19 ...
Exclusive: US cancels FDA bargaining session over layoffs, union says
The Trump administration last week canceled the first bargaining session scheduled with the U.S. Food and Drug Administration ...
US FDA names agency critic Vinay Prasad as top vaccine official
The U.S. Food and Drug Administration has named Vinay Prasad, an oncologist who has previously criticized FDA leadership and ...
OpenAI and US FDA hold talks about using AI in drug evaluation, Wired reports
OpenAI and the U.S. Food and Drug Administration have been meeting to discuss the health regulator's use of AI, technology ...
US court shuts down AstraZeneca's challenge to Medicare drug price plan
A federal appeals court on Thursday shut down AstraZeneca’s challenge to the U.S. government’s program that gives the ...
Exclusive: US FDA asks some fired pharma user fee negotiation staff to return
The U.S. Food and Drug Administration is asking some of its recently fired staff responsible for critically important funding ...
McKesson to spin off surgical supplies unit, forecasts strong annual profit
McKesson forecast fiscal 2026 profit largely above estimates on Thursday and said it is planning to spin off its medical-surgical solutions unit into an independent company to focus on its core drug ...
Wall Street rallies as first trade deal reached
U.S. stocks rallied on Thursday as investors cheered a new trade agreement hammered out between the United States and Britain ...
Drug maker Recordati's Q1 revenue rises 11.9%, confirms 2025 guidance
Italian drug maker Recordati posted an 11.9% increase in its first-quarter net revenue on Thursday to 680.0 million euros ($767.52 million) and confirmed its guidance for 2025.